Oramed to Present at the CODHy 6th World Congress on Diabetes, Obesity and Hypertension
JERUSALEM, Feb. 20, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming CODHy Conference, The 6th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension is taking place […]
